These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8708475)

  • 21. [Is macroangiopathy a complication of diabetes mellitus? I.Hyper- insulinemia].
    Goldsztajn P
    Przegl Lek; 1990; 47(7):551-6. PubMed ID: 2284423
    [No Abstract]   [Full Text] [Related]  

  • 22. [Atherogenic risk in diabetes: study of arteriosclerotic complications and their relationship with prolonged hypoglycemic treatment].
    Baraldi B; Cristini PD; Maestri G; Maj F; Cocuzza E; Angeli G
    Clin Ter; 1978 Jul; 86(1):37-53. PubMed ID: 743852
    [No Abstract]   [Full Text] [Related]  

  • 23. [Role of blood platelets in the pathogenesis of diabetic angiopathy].
    Brozyński K
    Pol Tyg Lek; 1986 Jun; 41(22):727-31. PubMed ID: 3529063
    [No Abstract]   [Full Text] [Related]  

  • 24. Risk factors of macrovascular disease in diabetes mellitus.
    Jarrett RJ
    Horm Metab Res Suppl; 1985; 15():1-3. PubMed ID: 3865876
    [No Abstract]   [Full Text] [Related]  

  • 25. Factors influencing the epidemiology of and interrelations between atherosclerosis and diabetes mellitus.
    Pfeiffer EF
    Acta Diabetol Lat; 1971 Sep; 8 Suppl 1():425-8. PubMed ID: 5146915
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes.
    Monnier L; Colette C; Leiter L; Ceriello A; Hanefeld M; Owens D; Tajima N; Tuomiletho J; Davidson J;
    Diabetes Care; 2007 Jan; 30(1):185-6; author reply 187-8. PubMed ID: 17192363
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes.
    Hirsch IB; Brownlee M
    Diabetes Care; 2007 Jan; 30(1):186-7; author reply 188-9. PubMed ID: 17192365
    [No Abstract]   [Full Text] [Related]  

  • 28. Peripheral vascular disease in diabetes mellitus.
    DeLawter DE
    Md Med J; 1990 Mar; 39(3):253-7. PubMed ID: 2319913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The hormone-metabolic changes in the diabetic angiopathy].
    Tat'ianenko LV; Shaposhnikova GI; Gulevskaia TS; Smirnov LD
    Vopr Med Khim; 1998; 44(1):55-62. PubMed ID: 9575613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of HDL cholesterol in diabetes mellitus in relation to various types of therapy].
    Floriani M; Spadoni M
    Quad Sclavo Diagn; 1984 Jun; 20(2):236-43. PubMed ID: 6396678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nutritional management of adult and juvenile diabetics.
    Bierman EL
    Curr Concepts Nutr; 1979; 8():107-17. PubMed ID: 527356
    [No Abstract]   [Full Text] [Related]  

  • 32. [Insulin: a cardiovascular risk factor?].
    Wirth A; Krone W
    Dtsch Med Wochenschr; 1988 Aug; 113(31-32):1250-4. PubMed ID: 3042349
    [No Abstract]   [Full Text] [Related]  

  • 33. Current concepts and controversies in the pathogenesis, prevention, and treatment of the macrovascular complications of diabetes.
    Mazzone T
    J Lab Clin Med; 2000 Jun; 135(6):437-43. PubMed ID: 10850642
    [No Abstract]   [Full Text] [Related]  

  • 34. [Arteriosclerosis risk factors in children and adolescents].
    Urban M; Krawczuk-Rybakowa M; Niewiarowska A
    Pediatr Pol; 1984 Feb; 59(2):163-8. PubMed ID: 6718108
    [No Abstract]   [Full Text] [Related]  

  • 35. [Macroangiopathy in diabetes mellitus].
    Janka HU
    Med Welt; 1983 Feb; 34(5):153-7. PubMed ID: 6843340
    [No Abstract]   [Full Text] [Related]  

  • 36. [Microangiopathic complications in type 2 diabetes].
    Strojek K; Grzeszczak W
    Wiad Lek; 1998; 51 Suppl 2():45-51. PubMed ID: 9686533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diabetic macroangiopathy].
    Oyarzábal M
    An Esp Pediatr; 1992; 37 Suppl 51():34-5. PubMed ID: 1492724
    [No Abstract]   [Full Text] [Related]  

  • 38. Daily insulin dose as a predictor of macrovascular disease in insulin treated non-insulin-dependent diabetics.
    Janka HU; Ziegler AG; Standl E; Mehnert H
    Diabete Metab; 1987 Jul; 13(3 Pt 2):359-64. PubMed ID: 3308565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Homocysteine and diabetic macroangiopathy].
    Araki A
    Nihon Rinsho; 2006 Nov; 64(11):2153-8. PubMed ID: 17087311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of HDL cholesterol in the etiology of peripheral vascular diseases in diabetes].
    Margarita-Aloj A; La Mastra RA; Guida C; Sarracino D; Peperoni G
    Minerva Cardioangiol; 1986 Oct; 34(10):663-9. PubMed ID: 3808335
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.